Skip to main content
Caplight Logo









SONIRE Therapeutics Inc.

SONIRE Therapeutics Inc.

Private
Palo Alto, CaliforniaHealthcare & Life Scienceshttps://www.sonire-therapeutics.com/

Last Round

Grant

Jun 17, 2026

Est. Valuation

$36.2M

Total Funding Raised

$52.84M

Momentum

Top 1%

of companies Caplight tracks

Company Overview

SONIRE Therapeutics Inc. is a clinical-stage medical device company that develops next-generation ultrasound-guided high-intensity focused ultrasound (HIFU) therapy systems for the non-invasive treatment of solid tumors, with an initial focus on pancreatic cancer.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Medical Imaging

Business Model

B2B

Customer Profile

Hardware Sales

AI Layer

Non-AI

Keywords

therapeutic ultrasoundhigh-intensity focused ultrasoundHIFUtumor ablationnon-invasive surgerymedical deviceimage-guided therapyinterventional radiologyoncology technologyfocused ultrasound surgeryFUScancer treatment hardwareminimally invasive oncologymedtech

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

SONIRE Therapeutics Inc. Comparables

Compare SONIRE Therapeutics Inc. with similar companies based on industry and business-model similarity.

SONIRE Therapeutics Inc. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
IMGT Co., Ltd.
78%
Sonablate Corp.
78%
Sound Blade Medical
77%

SONIRE Therapeutics Inc. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantJun 17, 2026
Series AApr 15, 2026
Series BNov 30, 2022
Series AJun 11, 2021

Key People

Founding team and executive leadership

Tohru Satoh

President CEO, Founder

Founding Team

Shin Yoshizawa

CTO

Executive Team

SONIRE Therapeutics Inc. Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 24, 2026

    Monthly visitors increased 49% MoM.

  • Jun 17, 2026

    $13M grant from New Energy and Industrial Technology Development Organization.

SONIRE Therapeutics Inc. Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

SONIRE Therapeutics Inc. Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about SONIRE Therapeutics Inc.'s valuation, stock price, and market status.

Firmographic Details

HeadquartersPalo Alto, California
Employee Range6
Year Founded2020
Last FundingJun 17, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?